116 related articles for article (PubMed ID: 8399690)
1. Utilization of drug sales data for the epidemiology of chronic diseases: the example of diabetes. The EURODIAB Subarea C Study Group.
Papoz L
Epidemiology; 1993 Sep; 4(5):421-7. PubMed ID: 8399690
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology in Malta from routine health information.
Schranz AG
Diabetes Res Clin Pract; 1994 May; 24(1):41-6. PubMed ID: 7924885
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of drug-treated diabetes mellitus in Belgium. Results of a study with the collaboration of a network of pharmacies.
Walckiers D; Van der Veken J; Papoz L; Stroobant A
Eur J Clin Pharmacol; 1992; 43(6):613-9. PubMed ID: 1493842
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of diabetes treated with drugs in Andalucía. Evolution of the oral antidiabetics and insulin prescription between 1994 and 2000].
Torrecilla Rojas MA; Ríos Bonin C; Fernández Fernández I
Rev Clin Esp; 2003 Sep; 203(9):426-9. PubMed ID: 14563255
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of diabetes in Switzerland: calculation based on drug sales].
Jirovec M; Teuscher A; Bürgi U; Diem P
Schweiz Med Wochenschr; 1993 Nov; 123(47):2247-50. PubMed ID: 8272797
[TBL] [Abstract][Full Text] [Related]
6. Prescribing of Antidiabetic Medicines before, during and after Pregnancy: A Study in Seven European Regions.
Charlton RA; Klungsøyr K; Neville AJ; Jordan S; Pierini A; de Jong-van den Berg LT; Bos HJ; Puccini A; Engeland A; Gini R; Davies G; Thayer D; Hansen AV; Morgan M; Wang H; McGrogan A; Nybo Andersen AM; Dolk H; Garne E
PLoS One; 2016; 11(5):e0155737. PubMed ID: 27192491
[TBL] [Abstract][Full Text] [Related]
7. Changes in diabetes prevalence and treatment in the last ten years in Luxembourg. A lesson from the United Kingdom prospective diabetes study?
Perquin M; Michel GH; de Beaufort C; Keipes M; Wirion R; Haas N
Diabetes Metab; 2005 Nov; 31(5):499-502. PubMed ID: 16357795
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence and consumption of medication in diabetes mellitus in Madrid (1996-2002)].
Arrieta FJ; Calvo MJ; Peréz A; Saavedra P; Cordobés FJ; Cabral R; Arrieta JJ; Rovira A
Rev Clin Esp; 2006 Mar; 206(3):117-21. PubMed ID: 16597376
[TBL] [Abstract][Full Text] [Related]
9. Patterns of prescription of hypoglycaemic drugs in Gran Canaria (Canary islands, Spain) and estimation of the prevalence of diabetes mellitus.
de Pablos-Velasco PL; Martínez-Martín FJ; Molero R; Rodríguez-Perez F; García-Puente I; Caballero A
Diabetes Metab; 2005 Nov; 31(5):457-62. PubMed ID: 16357789
[TBL] [Abstract][Full Text] [Related]
10. Trends and influences on use of antidiabetic drugs in England, 1992-2003.
Walley T; Hughes D; Kendall H
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):769-73. PubMed ID: 15768446
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and costs of diabetes treated with insulin in France.
Detournay B; Raccah D; Cadilhac M; Eschwège E
Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
[TBL] [Abstract][Full Text] [Related]
12. Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology.
Richter H; Dombrowski S; Hamer H; Hadji P; Kostev K
Ger Med Sci; 2015; 13():Doc14. PubMed ID: 26339224
[TBL] [Abstract][Full Text] [Related]
13. The prescribing of drugs used in the treatment of diabetes.
Wade OL; Hadden DR; Hood H
Br J Prev Soc Med; 1973 Feb; 27(1):44-8. PubMed ID: 4717800
[No Abstract] [Full Text] [Related]
14. Drug sales data and prevalence of diabetes in France.
Fontbonne A; Papoz L; Eschwege E
Rev Epidemiol Sante Publique; 1986; 34(2):100-5. PubMed ID: 3738066
[TBL] [Abstract][Full Text] [Related]
15. Use of antidiabetic and antihypertensive drugs in hospital and outpatient settings in Hong Kong.
Lau GS; Chan JC; Chu PL; Tse DC; Critchely JA
Ann Pharmacother; 1996 Mar; 30(3):232-7. PubMed ID: 8833556
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus in north Sweden: prevalence assessed from prescriptions for anti-diabetic agents.
Forrest RD
J Intern Med; 1990 Sep; 228(3):267-73. PubMed ID: 2205705
[TBL] [Abstract][Full Text] [Related]
17. Diabetes trends in Europe.
Passa P
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S3-8. PubMed ID: 12324978
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study.
Heinze G; Jandeck LM; Hronsky M; Reichardt B; Baumgärtel C; Bucsics A; Müllner M; Winkelmayer WC
Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):90-9. PubMed ID: 26468002
[TBL] [Abstract][Full Text] [Related]
19. Using a pharmaco-epidemiological approach to estimate diabetes type 2 prevalence in Portugal.
Duarte-Ramos F; Cabrita J
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):269-74. PubMed ID: 16294365
[TBL] [Abstract][Full Text] [Related]
20. The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden.
Bergman U; Elmes P; Halse M; Halvorsen T; Hood H; Lunde PK; Sjöqvist F; Wade OL; Westerholm B
Eur J Clin Pharmacol; 1975 Feb; 8(2):83-9. PubMed ID: 1233211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
